A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma
We present a generic dendritic cell (DC) vaccine strategy for patients with renal cell carcinoma (RCC) based on the use of RNA as a source of multiplex tumor-associated antigens (TAAs). Instead of preparing RNA from tumor tissue of each individual RCC patient, we propose to substitute RNA prepared f...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2005
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188079/ |